![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » Occlutech Grabs CE Mark for Atrial Flow Regulator
Occlutech Grabs CE Mark for Atrial Flow Regulator
![](https://www.fdanews.com/ext/resources/test/Device_Images6/Occlutech_Logo.png?t=1568072538&width=430)
September 9, 2019
Occlutech’s atrial flow regulator device has been cleared on the European market for treating heart failure symptoms through decompression.
The intra-atrial shunt is placed in the patient’s septum between the left and right atriums via a minimally invasive procedure to decompress abnormal pressure.
The device improves heart function by “maintaining the correct sizing of a created shunt,” the company said. The device comes in a variety of sizes to allow individualized treatment.
Upcoming Events
-
21Oct